Meet Dietmar Berger, Gilead Sciences CMO — Bio + How to Reach Out

Last updated: 2025-12-16

Who is Dietmar Berger?

Dietmar Berger, MD, PhD, is the Chief Medical Officer at Gilead Sciences, responsible for leading the company's virology, oncology, and inflammation pipeline. He has over 25 years of experience in developing innovative medicines across various therapeutic areas. Berger has held senior roles at Sanofi, Atara Biotherapeutics, Genentech, Bayer, and Amgen.

Dietmar Berger's Work History

He has a distinguished career in drug development, focusing on delivering transformational therapies in oncology, immunology, and infectious diseases. Berger joined Gilead in 2025 and oversees global development and medical affairs, contributing to the company's leadership in biopharmaceutical innovation.

• 2025-01 - Chief Medical Officer, Gilead Sciences
• 2020-02 - 2024-12 - Chief Medical Officer, Global Head of Development, Sanofi
• 2018-05 - 2019-05 - Global Head of Research and Development, Atara Biotherapeutics
• 2014-03 - 2018-05 - Senior Vice President, Global Clinical Development, Hematology/Oncology, Genentech
• 2011-12 - 2014-03 - Vice President, Global Clinical Development, Hematology/Oncology, Genentech
• 2009-10 - 2011-11 - Vice President, Global Clinical Development, Oncology, Bayer Healthcare
• 2005-10 - 2009-10 - Group Leader, Global Clinical Development, Hematology/Oncology, Amgen

Dietmar Berger's Education

Berger completed his medical training in Freiburg, Basel, and Chicago, earning an MD and PhD from the Albert-Ludwigs University School of Medicine. He is also a professor of medicine at the University of Freiburg Hospital.

• Albert-Ludwigs University School of Medicine - MD and PhD
• University of Freiburg - MD and PhD

How to Reach Dietmar Berger?

You can reach Dietmar Berger at *******@gilead sciences.com or by calling +1 **********. To get Dietmar Berger's contact information and other B2B leads like this, sign up for a free account at Anybody.com.